Genenta Science S.p.A. (ADR)
General ticker "GNTA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $71.2M (TTM average)
Genenta Science S.p.A. (ADR) does not follow the US Stock Market performance with the rate: -27.2%.
Estimated limits based on current volatility of 5.5%: low 1.85$, high 2.07$
Factors to consider:
- Total employees count: 7 as of 2021
Short-term GNTA quotes
Long-term GNTA plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €0.00MM | €0.00MM | €0.00MM |
| Operating Expenses | €11.04MM | €11.73MM | €9.76MM |
| Operating Income | €-11.04MM | €-11.73MM | €-9.76MM |
| Non-Operating Income | €2.57MM | €0.09MM | €0.85MM |
| R&D Expense | €5.34MM | €6.47MM | €4.81MM |
| Income(Loss) | €-8.48MM | €-11.65MM | €-8.91MM |
| Profit(Loss)* | €-8.48MM | €-11.65MM | €-8.91MM |
| Stockholders Equity | €31.14MM | €20.43MM | €12.50MM |
| Inventory | €0.14MM | €0.00MM | €0.00MM |
| Assets | €33.44MM | €22.35MM | €14.82MM |
| Operating Cash Flow | €-7.42MM | €-11.21MM | €-6.24MM |
| Capital expenditure | €0.03MM | €0.01MM | €0.00MM |
| Investing Cash Flow | €-0.03MM | €-14.89MM | €6.88MM |
| Financing Cash Flow | €0.00MM | €0.00MM | €0.27MM |
| Earnings Per Share** | €-0.47 | €-0.64 | €-0.49 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.